Zinc Alpha 2 Glycoprotein Monoclonal antibody

Zinc Alpha 2 Glycoprotein Monoclonal Antibody for IHC, WB,ELISA

Host / Isotype

Mouse / IgG1









Cat no : 66178-1-Ig


AZGP1, ZA2G, ZAG, Zinc alpha 2 glycoprotein, Zinc-alpha-2-glycoprotein, Zn alpha 2 glycoprotein, Zn alpha 2 GP, ZNGP1

Tested Applications

Positive WB detected inhuman plasma tissue
Positive IHC detected inhuman breast cancer tissue, human prostate cancer tissue, human prostate hyperplasia tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Sample-dependent, check data in validation data gallery

Product Information

66178-1-Ig targets Zinc Alpha 2 Glycoprotein in WB, IHC,ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivity human
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen Zinc Alpha 2 Glycoprotein fusion protein Ag5661
Full Name alpha-2-glycoprotein 1, zinc-binding
Calculated molecular weight 298 aa, 34 kDa
Observed molecular weight 41 kDa
GenBank accession numberBC033830
Gene symbol AZGP1
Gene ID (NCBI) 563
Conjugate Unconjugated
Form Liquid
Purification Method Protein G purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

Zinc-alpha-2-glycoprotein (AZGP1) is a 41-kDa soluble protein normally found in body fluids, functions as a lipid mobilizing factor (PMID: 19188554). It is known to be expressed in the secretory epithelia of the liver, lung, breast, GI tract and sweat glands, sharing significant structural similarity with the class I major histocompatibility complex (MHC) antigens (PMID: 3422450). AZGP1 is involved in carcinogenesis and differentiation. Altered expression of AZGP1 has been reported in breast cancer, prostate cancer and lung adenocarcinoma, hepatocellular carcinoma, pancreatic carcinoma and oral tumors (PMID: 22625427).


Product Specific Protocols
WB protocol for Zinc Alpha 2 Glycoprotein antibody 66178-1-IgDownload protocol
IHC protocol for Zinc Alpha 2 Glycoprotein antibody 66178-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Onco Targets Ther

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China.

Authors - Hong Tang